Key Takeaways & Executive Findings
- •• The ensemble surrogate model, integrating Kriging and radial basis function models, significantly improves prediction accuracy for coronary stent mechanical properties under limited sample sizes. • The proposed method achieves dual-objective optimization of stent radial stiffness and bending stiffness, outperforming single surrogate models. • The ensemble surrogate model reduces the inverse radial stiffness by up to 13.92% and improves bending stiffness by up to 2.56% compared to single models. • The framework offers a low-cost, high-precision solution for coronary stent design, addressing the trade-off between support and flexibility.
Abstract
BACKGROUND: Percutaneous coronary intervention stent implantation is primarily used to treat coronary artery stenosis. However, current multi-objective stent optimization methods are limited by sample size constraints, resulting in insufficient prediction accuracy when balancing key performance indicators such as support and compliance, hindering the effectiveness of stent optimization design. OBJECTIVE: To establish an innovative optimization framework for coronary stents based on a ensemble surrogate model. METHODS: A three-dimensional parametric model of the vascular stent was constructed, and a mechanical response database was established through finite element simulation. A dynamic weight fusion strategy was adopted to integrate the global optimization characteristics of the Kriging model and the local nonlinear representation advantages of the radial basis function model. A ensemble surrogate model was constructed based on 20 groups of initial samples, and the non-dominated sorting genetic algorithm-II was used to optimize the parameter space. RESULTS AND CONCLUSION: Experimental results demonstrated that the ensemble surrogate model exhibited significant advantages in the finite sample setting. The coefficient of determination for the inverse prediction of the radial stiffness of the stent reached 0.974 2, a 4.4% improvement compared to the single model, validating the efficient modeling capability of the ensemble surrogate model in the finite sample setting. The prediction accuracy of the stent's bending stiffness also improved by 4.4% compared to the single radial basis function surrogate model. After optimization, the stent performance achieved dual-objective synergistic optimization. The inverse radial stiffness of the stent in the ensemble surrogate model group was reduced by 13.92% and 9.57% compared to the Kriging model group and the single radial basis function surrogate model group, respectively. The bending stiffness of the stent was optimized by 0.38% and 2.56% compared to the Kriging model group and the single radial basis function surrogate model group, respectively. The proposed ensemble surrogate model breaks through the performance limitations of traditional single models, providing a low-cost, high-precision solution for the 'rigid-flexible' synergistic optimization of coronary stents.
1. Introduction
Percutaneous coronary intervention is a core treatment for coronary atherosclerotic heart disease, widely used for coronary artery stenosis through intravascular intervention to achieve revascularization [1-4]. However, the mechanical properties of currently used stents present a prominent contradiction: the support and flexibility of stents are difficult to optimize synergistically. Traditional metal stents (e.g., 316L stainless steel) have strong support but poor flexibility, which may lead to malapposition and distal vascular injury. New materials such as high-nitrogen nickel-free stainless steel improve flexibility but may reduce support, potentially causing acute collapse. This results in effective improvement of hemodynamics after stent implantation, but complications such as in-stent restenosis still limit long-term efficacy [5]. Therefore, further improving stent performance, especially reducing complications during long-term use, has become a research focus.
Finite element analysis has become a preferred method for studying stent performance due to its speed and low cost [6-9]. The geometric configuration of stents significantly affects their performance. For example, PANT et al. [10] found that the width and axial length of the stent ring cross-section significantly influence stent performance. SONG et al. [11] showed that insufficient support or excessive recoil can lead to severe complications such as acute collapse, late disruption, and malposition, further increasing cardiovascular risk. LI Ning et al. [12] emphasized that good flexibility not only ensures smooth passage through complex vessels but also reduces malapposition and vessel wall injury, thereby lowering restenosis rates. However, PANT et al. [10] found a trade-off between support and flexibility: improving support often affects flexibility and vice versa. To enhance overall performance, multi-objective optimization of stent design is needed.
By constructing surrogate models, the dynamic relationship between design variables and mechanical properties can be accurately mapped, effectively reducing optimization costs, computational noise, and iteration cycles [13]. Common surrogate models include Kriging [14], radial basis function (RBF) [15], and support vector machine models [16]. Existing stent multi-objective optimization methods often rely on a single surrogate model and require large sample data, which has obvious limitations in practice: when sample size is insufficient or multiple objectives are coupled, a single surrogate model struggles to simultaneously handle multiple objectives and complex engineering constraints [17]. To address this, some scholars have developed ensemble surrogate models to achieve better optimization performance. By integrating the strengths of different models, ensemble surrogate models can significantly improve optimization accuracy with limited samples, effectively balance multiple performance objectives, and yield better solutions than single models [18-19]. For example, ZHENG Linqing et al. [20] applied ensemble surrogate models to construct part surface topography, reducing measurement points and improving model accuracy; CHEN Yang et al. [21] used ensemble surrogate models in the lightweight design of bridge crane box girders, significantly improving structural optimization efficiency while achieving mass reduction.
Loading authentic research manuscript (Pages 1–5)...
ZHANG Ke, WANG Peiyao, WANG Bohan, ZHU Yuting, WANG Chuan (2026). Multi-objective optimization of coronary artery stent design in ensemble surrogate model. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21449
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is the main objective of this study?
The main objective is to establish an innovative optimization framework for coronary stents based on an ensemble surrogate model to achieve synergistic optimization of support and flexibility.
How does the ensemble surrogate model improve prediction accuracy?
The ensemble surrogate model integrates the global optimization characteristics of the Kriging model and the local nonlinear representation advantages of the radial basis function model using a dynamic weight fusion strategy, resulting in higher prediction accuracy compared to single models, especially with limited sample sizes.
What are the key performance indicators optimized in this study?
The key performance indicators are the radial stiffness (inverse) and bending stiffness of the coronary stent, representing support and flexibility, respectively.
What optimization algorithm is used?
The non-dominated sorting genetic algorithm-II (NSGA-II) is used to search the parameter space for optimal solutions.
What are the main findings of the study?
The ensemble surrogate model achieved a coefficient of determination of 0.9742 for inverse radial stiffness prediction, a 4.4% improvement over single models. After optimization, the inverse radial stiffness was reduced by up to 13.92% and bending stiffness improved by up to 2.56% compared to single models, demonstrating effective dual-objective optimization.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.